Showing results (401-410 of 1,023) with videos related to
Sort By:
Pageof 103
Cancer|August 15, 1991
Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemiaS O'Brien, H Kantarjian, E Estey, et al.American Journal of Human Genetics|November 1, 1978
Characterization of unusual hexosaminidase A (HEX A) deficient human mutantsJ S O'Brien, L Tennant, M L Veath, et al.Journal of Pediatric Surgery|August 1, 1983
The diagnosis and management of pyriform sinus fistulae in infants and young childrenD Miller, J L Hill, C C Sun, et al.The Journal of Rheumatology|January 19, 2010
Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictorsKristin M Ingraham, Marie S O'Brien, Max Shenin, et al.European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|February 16, 2013
Modifiable factors delaying early discharge following primary joint arthroplastyR J Napier, D Spence, O Diamond, et al.Cancer|August 1, 1997
Thiotepa for the treatment of thrombocythemia in patients with Philadelphia chromosome positive chronic myelogenous leukemiaE J Rodriguez-Monge, J E Cortes, S O'Brien, et al.Cancer Research|February 1, 1991
Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemiaS O'Brien, J A Benvenuto, E Estey, et al.Investigational New Drugs|November 11, 1999
Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: results of a randomized phase I/II studyN Vey, H Kantarjian, M Beran, et al.Prostate International|March 21, 2018
Reporting and ideal testosterone levels in men undergoing androgen deprivation for prostate cancer-time for a rethink?Sonja Cabarkapa, Marlon Perera, Ken Sikaris, et al.Patient Preference and Adherence|August 18, 2017
Simulating clinical trial visits yields patient insights into study design and recruitmentS Sam Lim, Alan J Kivitz, Doug McKinnell, et al.Pageof 103